Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|June 22, 2022
The impact of pretransplant serum ferritin on haploidentical hematopoietic stem cell transplant for acquired severe aplastic anemia in children and adolescentsFan Lin, Yangyang Zuo, Yuanyuan Zhang, et al.
Transplantation and Cellular Therapy|June 17, 2026
Risk factors and outcomes of Pneumocystis jirovecii pneumonia after allogeneic hematopoietic stem cell transplantation for hematological malignancy: A 10-year cohort studyQiusha Huang, Haoyue Cui, Xiaolu Zhu, et al.
British Journal of Haematology|June 26, 2024
Recent infection with SARS-CoV-2 in donors was associated with a higher incidence of acute graft-versus-host disease in recipients undergoing allogeneic haematopoietic stem cell transplantationFan Lin, Lanping Xu, Tingting Han, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 13, 2025
High-risk extranodal natural killer/T-cell lymphoma patients could benefit more from allogeneic hematopoietic stem cell transplantation as consolidation: A real-world multicenter analysis in ChinaYuewen Wang, Yi Xia, Zhenyang Gu, et al.
Cancer Letters|March 23, 2025
Allogeneic versus autologous hematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: A real-world multicenter analysis in ChinaYuewen Wang, Weiping Liu, Zhenyang Gu, et al.
Cancer|January 6, 2025
Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a-rearranged acute myeloid leukemiaLulu Wang, Yuxiu Chen, Mengtong Zang, et al.
Bone Marrow Transplantation|December 1, 2022
Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infectionXueyan Sun, Haixia Fu, Chencong Wang, et al.
Bone Marrow Transplantation|January 8, 2021
Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive modelsXueyan Sun, Yan Su, Xiao Liu, et al.
BMC Medicine|February 27, 2024
Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trialHaixia Fu, Xueyan Sun, Ren Lin, et al.
Cancer Letters|January 13, 2025
Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationMenglin Li, Yimeng Li, Qingyuan Qu, et al.
Pageof 10